Journal article icon

Journal article

Toward operative in vivo fluorescence imaging of the c‐Met proto‐oncogene for personalization of therapy in ovarian cancer

Abstract:

BACKGROUND: Standard biomarker testing of a single macroscopic disease site is unlikely to be sufficient because of tumor heterogeneity. A focus on examining global biomarker expression or activity, particularly in microscopic residual chemotherapy‐resistant disease, is needed for the appropriate selection of targeted therapies. This study was aimed at establishing a technique for the assessment of biomarkers of ovarian cancer peritoneal spread.

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/cncr.29029

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
Expand authors...
Medical Research Council More from this funder
Cancer Research UK More from this funder
Publisher:
Wiley Publisher's website
Journal:
Cancer Journal website
Volume:
121
Issue:
2
Pages:
202-213
Publication date:
2014-09-10
Acceptance date:
2014-07-21
DOI:
EISSN:
1097-0142
ISSN:
0008-543X
Pmid:
25209149
Source identifiers:
484035
Language:
English
Keywords:
Pubs id:
pubs:484035
UUID:
uuid:fb969b02-9cc8-4a97-8988-aa1f5f1e76e6
Local pid:
pubs:484035
Deposit date:
2018-04-04

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP